|Videos|April 10, 2017

Preliminary Results of Coxsackievirus With Pembrolizumab In Advanced Melanoma

Ann W. Silk, MD, discusses preliminary results of the CAPRA trial, a phase 1B study of intratumoral coxsackievirus A21 (CVA21; CAVATAK) and systemic pembrolizumab in patients with advanced melanoma.


Latest CME